Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (271-280 of 352) with videos related to

Pageof 36
Sort By:
Gut|July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trialRemo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Inflammatory Bowel Diseases|July 29, 2009
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose studyWalter Reinisch, Williem de Villiers, László Bene, et al.
The New England Journal of Medicine|December 13, 2005
Infliximab for induction and maintenance therapy for ulcerative colitisPaul Rutgeerts, William J Sandborn, Brian G Feagan, et al.
Inflammatory Bowel Diseases|April 13, 2011
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studiesWalter Reinisch, William J Sandborn, Paul Rutgeerts, et al.
Wiener Klinische Wochenschrift|October 19, 2007
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel diseaseAlexander Teml, Matthias Schwab, Daan W Hommes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2021
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United StatesManasi Agrawal, Erica J Brenner, Joyce Wing Yan Mak, et al.
Inflammatory Bowel Diseases|January 31, 2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD TrialJulian Panés, Gerd Bouma, Marc Ferrante, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2023
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled TrialsAxel Dignass, Wolfgang Stremmel, Marek Horyński, et al.
Gastroenterology|July 5, 2011
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitisJean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, et al.
Inflammatory Bowel Diseases|January 9, 2009
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot studyMaria T Abreu, Christian von Tirpitz, Robert Hardi, et al.
Pageof 36

Showing results (271-280 of 352) with videos related to

Sort By:
Pageof 36
Gut|July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trialRemo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Inflammatory Bowel Diseases|July 29, 2009
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose studyWalter Reinisch, Williem de Villiers, László Bene, et al.
The New England Journal of Medicine|December 13, 2005
Infliximab for induction and maintenance therapy for ulcerative colitisPaul Rutgeerts, William J Sandborn, Brian G Feagan, et al.
Inflammatory Bowel Diseases|April 13, 2011
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studiesWalter Reinisch, William J Sandborn, Paul Rutgeerts, et al.
Wiener Klinische Wochenschrift|October 19, 2007
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel diseaseAlexander Teml, Matthias Schwab, Daan W Hommes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2021
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United StatesManasi Agrawal, Erica J Brenner, Joyce Wing Yan Mak, et al.
Inflammatory Bowel Diseases|January 31, 2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD TrialJulian Panés, Gerd Bouma, Marc Ferrante, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2023
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled TrialsAxel Dignass, Wolfgang Stremmel, Marek Horyński, et al.
Gastroenterology|July 5, 2011
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitisJean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, et al.
Inflammatory Bowel Diseases|January 9, 2009
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot studyMaria T Abreu, Christian von Tirpitz, Robert Hardi, et al.
Pageof 36